Sanguine BioSciences, Inc. announced that it has received $10 million in funding from Heliant Ventures, Invent Ventures, Inc., and other investors.
On February 21, 2013, Sanguine BioSciences, Inc. closed the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0112 USD | +12.00% | 0.00% | -66.06% |
2018 | Invent Ventures, Inc. acquired all assets from Revenue.com US Corporation. | CI |
2017 | Invent Ventures, Inc. Announces Management Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-66.06% | 1.06M | |
+3.94% | 46.57B | |
+22.31% | 13.25B | |
+22.98% | 7.58B | |
+2.52% | 7.53B | |
-2.41% | 3.3B | |
+17.20% | 1.94B | |
+15.50% | 1.89B | |
-5.79% | 1.31B | |
+4.39% | 1.29B |